306 related articles for article (PubMed ID: 12521085)
1. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
2. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
4. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of polyamine assay in diagnosis of malignant ascites].
Peng A; Zhao S; Zhang X; Zhang G
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):59-62, 65. PubMed ID: 9868032
[TBL] [Abstract][Full Text] [Related]
6. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
7. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
9. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
Khan FY
Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fibronectin as a marker of malignant ascites.
Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
[TBL] [Abstract][Full Text] [Related]
12. Ascitic fluid cholesterol in differential diagnosis of ascites.
Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
[TBL] [Abstract][Full Text] [Related]
13. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
[TBL] [Abstract][Full Text] [Related]
14. [Fibronectin in the ascitic fluid: its diagnostic significance].
Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
[TBL] [Abstract][Full Text] [Related]
16. Measurement of fibronectin concentration in benign and malignant ascites.
Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
[TBL] [Abstract][Full Text] [Related]
17. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
18. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of ascitic fluid].
González Maldonado JJ
Rev Gastroenterol Mex; 1993; 58(2):170-2. PubMed ID: 7747028
[TBL] [Abstract][Full Text] [Related]
20. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites.
Dwivedi M; Misra SP; Misra V; Kumar R
Am J Gastroenterol; 1990 Sep; 85(9):1123-5. PubMed ID: 2389724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]